Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL455958 | 1.00 | RAB9A (0.34) | RAB9AKDM4ENPC1SMN1; SMN2THRB | |
| SCHEMBL10989953 | 0.83 | TOP2A (0.37) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL8412572 | 0.83 | TOP2A (0.37) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL15193068 | 0.83 | TOP2A (0.37) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL13614213 | 0.81 | RAB9A (0.38) | RAB9AKDM4ENPC1SMN1; SMN2THRB | |
| SCHEMBL16976870 | 0.80 | RAB9A (0.38) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL16976823 | 0.80 | RAB9A (0.38) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL12035124 | 0.78 | RAB9A (0.38) | RAB9AKDM4ENPC1SMN1; SMN2 | |
| SCHEMBL441609 | 0.76 | RAB9A (0.37) | RAB9AKDM4ENPC1SMN1; SMN2THRB | |
| SCHEMBL13531627 | 0.76 | RAB9A (0.34) | RAB9AKDM4ENPC1SMN1; SMN2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010083597-A1 | METHODS OF MAKING LUBIPROSTONE AND INTERMEDIATES THEREOF | APOTEX PHARMACHEM INC. (CA) | 2010-07-29 | — | — | WO | disclosed |